JAK inhibitors in dermatology: the promise of a new drug class. J Am Acad Dermatol 2017;76:736-44.Damsky, W. and B.A. King, JAK inhibitors in dermatology: The promise of a new drug class. J Am Acad Dermatol, 2017. 76(4): p. 736-744....
1. 叶水送,《华人学者认为与导师合作有望问鼎诺奖,背后的争论何在?》,https://zhuanlan.zhihu.com/p/29973250 2. R Shreberk-Hassidim , Y Ramot , A Zlotogorski,《Janus kinase inhibitors in dermatology: A systematic review》,Journal of the American Academy of Dermatology , 2017 , 76(4) :745-7...
参考文献 Taylor, C. R., & Erkek, E. (2019). JAK inhibitors in dermatology: A new therapeutic option for vitiligo. Journal of the American Academy of Dermatology, 80(2), 479-482. Parsad, D., & Pandey, S. S. (2019). JAK inhibitors in vitiligo: A new hope. Indian Journal of Der...
2. R Shreberk-Hassidim , Y Ramot , A Zlotogorski,《Janus kinase inhibitors in dermatology: A systematic review》,Journal of the American Academy of Dermatology , 2017 , 76(4) :745-753 3. Sandborn WJ, Su C, Sands BE, D'Haens ...
EP.1:Introduction to Janus Kinase (JAK) Inhibitors in Dermatology Care EP.2:Current FDA Approved JAK Inhibitors Use in Dermatological Care EP.3:Safety and FDA Warnings for JAK Inhibitors in Dermatological Care EP.4:Expert Perspectives into the Utilization of JAK Inhibitors in Patients with Derma...
参考文献:1. Chapman S, Kwa M, Gold LS, Lim HW. Janus kinase inhibitors in dermatology: Part I. A comprehensive review. J Am Acad Dermatol. 2022;86(2):406-413.2. Dudley AC, Thomas D, Best J, Jenkins A. The STATs in cell stress-type responses. Cell Commun Signal. 2004;2(1):8....
Solimani, F., Meier, K., & Ghoreschi, K. (2019). Emerging topical and systemic JAK inhibitors in dermatology. Frontiers in immunology, 10, 2847 Prevalence of Acne Inversa (Hidradenitis Suppurativa) in China: A Nation...
Insights, current status and future perspective of JAK inhibitors in the treatment of alopecia areata ZHANG Xingqi Author information + 文章历史 + 摘要 斑秃是一种慢性、异质性炎症性疾病,确切病因未明,虽治疗方法众多,但无特效药,也无对所有患者有效的疗法,加之部分慢性、重度患者对常规治疗反应差,因...
Hot Topic: JAK Inhibitors In this video interview, Benjamin N. Ungar, MD, assistant professor of dermatology and director of the Rosacea & Seborrheic Dermatitis Clinic at Mount Sinai, discussed: current JAK inhibitors approved to treat atopic dermatitis; positioning different JAK inhibitors; using ...
Topical corticosteroid phobia in atopic dermatitis: a systematic review. JAMA Dermatology. 2017;153(10):1036–1042. 5.Harrington R, Al Nokhatha SA, Conway R. JAK inhibitors in rheumatoid arthritis: an evidence-based review on the emerging clinical data. J Inflamm Res. 2020;13:519–531. 6....